AI-Designed Drugs Hit 90% Phase I Success Rate
Machine learning platforms are outperforming traditional drug discovery methods in early human trials.
In-depth coverage, analysis, and updates on AI Drug Discovery in AI and tech. 4 articles on The Pulse Gazette.
Machine learning platforms are outperforming traditional drug discovery methods in early human trials.
The molecule was designed entirely by AI in 18 months instead of the typical 5 years. Phase 3 trials begin next month.
Traditional drug discovery takes 10 years. AI found a novel antibiotic compound in an afternoon. Clinical trials start next month.
From target identification to clinical trials, AI drove every step. This changes pharmaceutical R&D forever.